The MRC/HPS study treatment of HF patients with 40 mg simvastatin daily showed a non-significant trend toward lower HF deaths rate due to any cause and a marginally significant reduction in first hospital admission for worsening HF or HF death 36 , 37 .
← all excerpts
Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.
1
—
—